Superdisintegrants Market – Worldwide Growth Anticipated 2022

• Analysis
• 15-November-2016

The global superdisintegrants market has been largely driven by growing geriatric & pediatric population base and emerging superdisintegrants industry. Additionally, the expanding generic drugs market will also aid in the growth of the market in the near future. The increasing market in the emerging economies is anticipated to open new growth avenues for the industry players. However, lack of expenditure on research and development field for the development of innovative superdisintegrants is a major restraint, which may hinder the growth of the market in the forthcoming years.
 
The report on “Global Superdisintegrants Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast” available at DecisionDatabases.com covers the market overview, market size, growth trends and future prospects of this industry. Superdisintegrants are substances, used to disintegrate capsule content into particles when added to the drug formulation. These facilitate safer and effective drug delivery with patient's compliance by giving rapid dissolving ability to drugs. Solid orals dosage has gained maximum popularity among other dosage forms. Over the past few years, the emergence of superdisintegrants has contributed a rapid pace to the pharmaceutical industry by ensuring right tablet-dissolution ability to meet formulation needs. It has given a new functionality to the ingredients used for drug development along with a full-service resource to meet up all the formulation needs. 

 
The global superdisintegrants market has been segmented based on product into natural superdisintegrants, synthetic superdisintegrants and others. Synthetic superdisintegrant product segment includes modified starch, modified cellulose, low-substituted hydroxypropyl cellulose, crospovidone, ion exchange resins and calcium silicates. The synthetic superdisintegrant segment has accounted for the largest market share and is expected to witness a double-digit growth during the forecast period on account of the widespread usage of the products in orally and fast disintegrating tablets for cardiovascular, neurological, and other related diseases across the globe. The market has been further segmented based on applications into tablets and capsules. Furthermore, the market has been segmented based on therapeutic area.

North America is a major superdisintegrants market and has accounts for major market share compared to other regions. The factors attributed to the growth of the market includes rising R&D expenditure for the development of new oral dosage drugs along with the continuous efforts by players to provide effective, compliant and superior quality products in the region.

Asia Pacific is a fastest growing market owing to the rising healthcare spending, increasing health awareness, expanding healthcare infrastructure and increasing outsourcing of synthetic superdisintegrants products particularly to India and China.
   
Key industry players whose complete profile and financial analysis is covered in the report are Ashland Inc., BASF SE, FMC Corporation, DFE Pharma, JRS Pharma, Roquette, The DOW Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., Ltd. and Huber Corporation. The global market is consolidated in nature due to the availability of few major players and they compete on the basis of innovative product development and new product launch in the market.
   
 About-Us:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
 
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
 
 For more details:
DecisionDatabases.com                    
E-Mail:  [email protected]
Phone: +91 99 28 237112
Web: www.decisiondatabases.com/